Science
Pipeline
Company
News
Contact Us
Contact Us
Latest Updates
Interview
Diasome's Liver Targeted Insulin with Robert Geho
April 18, 2019
Share this article
Interview
Latest Updates
News
Press Release
Diasome Pharmaceuticals Completes Enrollment in Phase 2b OPTI-2 Trial of HDV-Insulin Lispro for Type 1 Diabetes
View Article
Press Release
Diasome's CMO, Dr. Marc Penn, to Unveil Innovative Diabetes Research at ADA Scientific Sessions
View Article
Study
Divergent Hypoglycemic Effects of Hepatic-Directed Prandial Insulin: A 6-Month Phase 2b Study in Type 1 Diabetes
View Article
View All